The Food and Drug Administration (FDA) informs the public on the claims of Nasal Spray products authorized in the Philippines.
These Nasal Spray products have been authorized as medical devices which are intended for short-term use in the nasal cavity and serves as mechanical barrier from particulates. These are sprays that coat the nasal mucosa with substances that have a non-specific effect against pathogens. The products do not have active pharmaceutical ingredients that directly treat, eliminate or prevent diseases. They should not be used as substitutes to medicines and vaccines to prevent or treat SARS-CoV-2 Infection or COVID-19. The public is further encouraged to be vigilant in using products with claims against prevention or treatment of the COVID-19 disease.
For more information and inquiries, kindly contact the FDA – Center for Device Regulation, Radiation Health, and Research through e-mail at [email protected] or call (02) 8857-1900 loc. 8301.
Dissemination of this advisory is hereby requested.